DK0769956T3 - Anvendelse af en GnRH-antogonist til fremstilling af et medikament til behandling af gonadal-steroidafhængige tilstande - Google Patents

Anvendelse af en GnRH-antogonist til fremstilling af et medikament til behandling af gonadal-steroidafhængige tilstande

Info

Publication number
DK0769956T3
DK0769956T3 DK95927228T DK95927228T DK0769956T3 DK 0769956 T3 DK0769956 T3 DK 0769956T3 DK 95927228 T DK95927228 T DK 95927228T DK 95927228 T DK95927228 T DK 95927228T DK 0769956 T3 DK0769956 T3 DK 0769956T3
Authority
DK
Denmark
Prior art keywords
antogonist
gnrh
drug
preparation
treatment
Prior art date
Application number
DK95927228T
Other languages
Danish (da)
English (en)
Inventor
Gary D Hodgen
Audrey Philips
Original Assignee
Hampton Roads Medical College
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26959766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0769956(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/467,860 external-priority patent/US5658884A/en
Application filed by Hampton Roads Medical College, Ortho Pharma Corp filed Critical Hampton Roads Medical College
Application granted granted Critical
Publication of DK0769956T3 publication Critical patent/DK0769956T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95927228T 1994-07-22 1995-07-18 Anvendelse af en GnRH-antogonist til fremstilling af et medikament til behandling af gonadal-steroidafhængige tilstande DK0769956T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27959394A 1994-07-22 1994-07-22
US08/467,860 US5658884A (en) 1994-07-22 1995-06-06 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
PCT/US1995/008996 WO1996003138A1 (fr) 1994-07-22 1995-07-18 Procede pour assurer une secretion tonique d'oestrogene ovarien dans des regimes therapeutiques de longue duree

Publications (1)

Publication Number Publication Date
DK0769956T3 true DK0769956T3 (da) 2000-06-05

Family

ID=26959766

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95927228T DK0769956T3 (da) 1994-07-22 1995-07-18 Anvendelse af en GnRH-antogonist til fremstilling af et medikament til behandling af gonadal-steroidafhængige tilstande

Country Status (29)

Country Link
EP (1) EP0769956B1 (fr)
JP (1) JP3138477B2 (fr)
CN (1) CN1137722C (fr)
AP (1) AP775A (fr)
AT (1) ATE190494T1 (fr)
AU (1) AU691952B2 (fr)
BG (1) BG63363B1 (fr)
BR (1) BR9508718A (fr)
CA (1) CA2195745C (fr)
CY (1) CY2228B1 (fr)
CZ (1) CZ291803B6 (fr)
DE (1) DE69515666T2 (fr)
DK (1) DK0769956T3 (fr)
EE (1) EE03515B1 (fr)
ES (1) ES2145286T3 (fr)
FI (1) FI970244A (fr)
GR (1) GR3033590T3 (fr)
HU (1) HU218910B (fr)
IL (1) IL114655A (fr)
IS (1) IS4413A (fr)
LV (1) LV11823B (fr)
MX (1) MX9700574A (fr)
NO (1) NO970257L (fr)
NZ (1) NZ290554A (fr)
OA (1) OA10730A (fr)
PT (1) PT769956E (fr)
RU (1) RU2181598C2 (fr)
SK (1) SK282118B6 (fr)
WO (1) WO1996003138A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
NZ534836A (en) * 1999-09-23 2007-07-27 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
GB0616111D0 (en) * 2006-06-16 2006-09-20 Ardana Bioscience Ltd Agents, methods and uses
EP2095818A1 (fr) * 2008-02-29 2009-09-02 AEterna Zentaris GmbH Utilisation d'antagonistes LHRH dans des doses n'impliquant pas de castration
US20110129532A1 (en) * 2008-05-29 2011-06-02 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
WO2016184829A1 (fr) * 2015-05-18 2016-11-24 Nerre Therapeutics Limited Antagonistes doubles des récepteurs nk-1/nk-3 pour le traitement de maladies dépendant des hormones sexuelles
EP3560555A1 (fr) * 2018-04-26 2019-10-30 LifeArc Composition pour traiter une ou plusieurs maladies liées aux strogènes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
JP3138477B2 (ja) 2001-02-26
AP9700913A0 (en) 1997-01-31
ATE190494T1 (de) 2000-04-15
IL114655A (en) 2005-08-31
JPH10503203A (ja) 1998-03-24
OA10730A (en) 2001-06-07
AP775A (en) 1999-10-28
EE9700208A (et) 1998-02-16
CY2228B1 (en) 2003-04-18
FI970244A0 (fi) 1997-01-21
ES2145286T3 (es) 2000-07-01
HU218910B (hu) 2000-12-28
EP0769956B1 (fr) 2000-03-15
NZ290554A (en) 2000-08-25
RU2181598C2 (ru) 2002-04-27
WO1996003138A1 (fr) 1996-02-08
NO970257D0 (no) 1997-01-21
IL114655A0 (en) 1995-11-27
LV11823A (lv) 1997-08-20
EE03515B1 (et) 2001-10-15
PT769956E (pt) 2000-07-31
CN1200674A (zh) 1998-12-02
CZ291803B6 (cs) 2003-06-18
DE69515666T2 (de) 2000-07-06
IS4413A (is) 1997-01-14
HUT77127A (hu) 1998-03-02
CZ15097A3 (en) 1997-11-12
HU9700046D0 (en) 1997-02-28
SK7097A3 (en) 1997-11-05
EP0769956A4 (fr) 1999-03-10
GR3033590T3 (en) 2000-09-29
AU3132095A (en) 1996-02-22
BG101158A (en) 1997-09-30
BG63363B1 (bg) 2001-11-30
NO970257L (no) 1997-01-21
EP0769956A1 (fr) 1997-05-02
DE69515666D1 (de) 2000-04-20
LV11823B (en) 1998-03-20
MX9700574A (es) 1997-12-31
AU691952B2 (en) 1998-05-28
CN1137722C (zh) 2004-02-11
FI970244A (fi) 1997-01-21
CA2195745A1 (fr) 1996-02-08
BR9508718A (pt) 1997-12-30
CA2195745C (fr) 2005-03-29
SK282118B6 (sk) 2001-11-06

Similar Documents

Publication Publication Date Title
BR9509753A (pt) Sistema de infusão remotamente programável
DE69224892D1 (de) Implantierbare Infusionsvorrichtung
DE69632852D1 (de) Teleskopischer katheter
FI971279A (fi) Lääkkeitä
DE69626168D1 (de) Infusionskatheter
FI964452A0 (fi) Atsitromysiinin kontrolloidun vapautumisen annostusmuotoja
DK93892A (da) Fremgangsmaade til fremstilling af et depotpraeparat
ATE193298T1 (de) Therapeutische verbindungen
NO933244D0 (no) Ampulle
DE69316376D1 (de) Inhalationsvorrichtung
DK19893D0 (da) Praeparat til nasal behandling
DE69522165T2 (de) Mikrokreisel
BR9303328A (pt) Dispositivo de acoplamento
ID23780A (id) Nitrik oksida penghambat infeksi phinovirus
DK0769956T3 (da) Anvendelse af en GnRH-antogonist til fremstilling af et medikament til behandling af gonadal-steroidafhængige tilstande
IT1304370B1 (it) Dispositivo per l'agugliatura di un'ovatta.
DK0735905T3 (da) Anordning til fastgørelse af enderne af kateterledetråde
DK101197A (da) Medikament til behandling af thrombocytopenia
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
DE59807173D1 (de) Einrichtung zur verstellung der länge einer stütze
FR2687579B1 (fr) Dispositif d'obturation.
ITTO920091U1 (it) Dispositivo stringitubo per apparecchi medicali.
FI2364U1 (fi) Karstattu neulosputki
ATE163865T1 (de) Unabhängige infusionsvorrichtung
BR9204079A (pt) Dispositivo injetor de argamassa